(Q37688031)

22 August 2017

1 reference

title

Antidiabetic oral treatment in older people: does frailty matter? (English)

1 reference

22 August 2017

2

1 reference

22 August 2017

5

Fabrizia Lattanzio

1 reference

22 August 2017

1

Angela Marie Abbatecola

1 reference

22 August 2017

Andrea Corsonello

3

1 reference

PubMed ID

20136169

22 August 2017

Silvia Bustacchini

series ordinal

4

1 reference

22 August 2017

1 December 2009

1 reference

22 August 2017

1 reference

22 August 2017

26 Suppl 1

1 reference

22 August 2017

53-62

1 reference

https://scigraph.springernature.com/pub.10.2165/11534660-000000000-00000

22 August 2017

0 references

cites work

The effect of diabetes on disability in middle-aged and older adults.

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11534660-000000000-00000

Toward an understanding of frailty

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11534660-000000000-00000

Insulin resistance and executive dysfunction in older persons

21 January 2018

1 reference

12 December 2020

Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes

1 reference

12 December 2020

Progression of lower-extremity disability in older women with diabetes: the Women's Health and Aging Study

1 reference

12 December 2020

Alpha-glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis

1 reference

12 December 2020

Relationships between hyperglycemia and cognitive performance among adults with type 1 and type 2 diabetes

1 reference

12 December 2020

Gliclazide modified release: its place in the therapeutic armamentarium.

1 reference

12 December 2020

Older women with diabetes have a higher risk of falls: a prospective study

1 reference

12 December 2020

Metformin and its liver targets in the treatment of type 2 diabetes

1 reference

12 December 2020

Improving metabolic control leads to better working memory in adults with type 2 diabetes.

1 reference

12 December 2020

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

1 reference

12 December 2020

Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults

1 reference

12 December 2020

Relation of diabetes to mild cognitive impairment.

1 reference

12 December 2020

Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes

1 reference

12 December 2020

Comorbidities and impairments explaining the association between diabetes and lower extremity disability: The Women's Health and Aging Study

1 reference

12 December 2020

Postprandial plasma glucose excursions and cognitive functioning in aged type 2 diabetics.

1 reference

12 December 2020

Diabetes as a predictor of change in functional status among older Mexican Americans: a population-based cohort study

1 reference

12 December 2020

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial

1 reference

12 December 2020

Safety of type 2 diabetes treatment with repaglinide compared with glibenclamide in elderly people: A randomized, open-label, two-period, cross-over trial

1 reference

12 December 2020

Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort.

1 reference

12 December 2020

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Diabetes and physical disability among older U.S. adults

1 reference

12 December 2020

New approaches to treating type 2 diabetes mellitus in the elderly: role of incretin therapies.

1 reference

12 December 2020

Repaglinide versus nateglinide monotherapy: a randomized, multicenter study

1 reference

12 December 2020

The physics of frailty

1 reference

12 December 2020

Establishing pragmatic estimated GFR thresholds to guide metformin prescribing

1 reference

12 December 2020

Treatment of diabetes in the elderly. Addressing its complexities in this high-risk group

1 reference

12 December 2020

Cognitive decline and dementia in diabetes--systematic overview of prospective observational studies

1 reference

12 December 2020

Diabetes, sarcopenia, and frailty

1 reference

12 December 2020

Pharmacology of the meglitinide analogs: new treatment options for type 2 diabetes mellitus

1 reference

12 December 2020

1 reference

12 December 2020

Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis

1 reference

12 December 2020

Glycemia and cognitive function in older adults using glucose-lowering drugs.

1 reference

12 December 2020

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

1 reference

12 December 2020

Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes.

1 reference

12 December 2020

Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis

1 reference

12 December 2020

Biological effects and metabolic rates of glucagonlike peptide-1 7-36 amide and glucagonlike peptide-1 7-37 in healthy subjects are indistinguishable

1 reference

12 December 2020

Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study.

1 reference

12 December 2020

Management of diabetes in the elderly: a clinical perspective

1 reference

12 December 2020

Frailty in the elderly: contributions of sarcopenia and visceral protein depletion

1 reference

12 December 2020

Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study

1 reference

12 December 2020

Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes

1 reference

12 December 2020

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

1 reference

12 December 2020

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

12 December 2020

Association of diabetes mellitus and dementia: the Rotterdam Study.

1 reference

12 December 2020

Individualising therapy for older adults with diabetes mellitus

1 reference

12 December 2020

The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial

1 reference

12 December 2020

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

1 reference

12 December 2020

Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials

1 reference

12 December 2020

Is there a relationship between insulin resistance and frailty syndrome?

1 reference

12 December 2020

Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial

1 reference

12 December 2020

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

1 reference

12 December 2020

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

1 reference

12 December 2020

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

1 reference

12 December 2020

Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus

1 reference

12 December 2020

Ageing and diabetes: implications for brain function

1 reference

12 December 2020

Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study

1 reference

12 December 2020

Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea

1 reference

12 December 2020

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

1 reference

12 December 2020

10.2165/11534660-000000000-00000

Identifiers

DOI

1 reference

PubMed ID

20136169

Dimensions Publication ID

22 August 2017

0 references

1 reference

PubMed ID

20136169